141 related articles for article (PubMed ID: 18633224)
41. Preliminary study of combination therapy with interferon-alpha and zinc in chronic hepatitis C patients with genotype 1b.
Nagamine T; Takagi H; Takayama H; Kojima A; Kakizaki S; Mori M; Nakajima K
Biol Trace Elem Res; 2000; 75(1-3):53-63. PubMed ID: 11051596
[TBL] [Abstract][Full Text] [Related]
42. Taste and smell disturbances in cancer patients: a scoping review of available treatments.
Sevryugin O; Kasvis P; Vigano M; Vigano A
Support Care Cancer; 2021 Jan; 29(1):49-66. PubMed ID: 32734392
[TBL] [Abstract][Full Text] [Related]
43. A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders.
Lyckholm L; Heddinger SP; Parker G; Coyne PJ; Ramakrishnan V; Smith TJ; Henkin RI
J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):111-4. PubMed ID: 22764846
[TBL] [Abstract][Full Text] [Related]
44. [A case of polaprezinc-induced pneumonitis].
Eto S; Yoshinaga T; Ushijima S; Saishoji T
Nihon Kokyuki Gakkai Zasshi; 2003 Aug; 41(8):561-4. PubMed ID: 14503344
[TBL] [Abstract][Full Text] [Related]
45. [Clinical study of taste abnormalities in advanced lung cancer cases].
Maeda K; Katada H; Mikasa K; Konishi M; Shimoyama T; Fukuoka K; Tsujimoto M; Sawaki M; Narita N
Gan No Rinsho; 1989 Nov; 35(14):1631-5. PubMed ID: 2593229
[TBL] [Abstract][Full Text] [Related]
46. Polaprezinc, a gastroprotective agent: attenuation of monochloramine-evoked gastric DNA fragmentation.
Suzuki H; Mori M; Seto K; Nagahashi S; Kawaguchi C; Morita H; Suzuki M; Miura S; Yoneta T; Ishii H
J Gastroenterol; 1999; 34 Suppl 11():43-6. PubMed ID: 10616765
[TBL] [Abstract][Full Text] [Related]
47. Induction of type 1 interferon receptor by zinc in U937 cells.
Nagamine T; Nakajima K; Takada H; Sekine Y; Suzuki K
Cytokine; 2009 Jun; 46(3):346-50. PubMed ID: 19362011
[TBL] [Abstract][Full Text] [Related]
48. Comparison of zinc acetate hydrate and polaprezinc for zinc deficiency in patients on maintenance hemodialysis: A single-center, open-label, prospective randomized study.
Okamoto T; Hatakeyama S; Konishi S; Okita K; Tanaka Y; Imanishi K; Takashima T; Saitoh F; Suzuki T; Ohyama C
Ther Apher Dial; 2020 Oct; 24(5):568-577. PubMed ID: 31794152
[TBL] [Abstract][Full Text] [Related]
49. Electron microscopic observation of vallate taste buds of zinc-deficient rats with taste disturbance.
Kobayashi T; Tomita H
Auris Nasus Larynx; 1986; 13 Suppl 1():S25-31. PubMed ID: 3767772
[TBL] [Abstract][Full Text] [Related]
50. Beneficial effect of polaprezinc on cardiac function post-myocardial infarction: A prospective and randomized clinical trial.
Yoshikawa F; Nakajima T; Hanada M; Hirata K; Masuyama T; Aikawa R
Medicine (Baltimore); 2019 Mar; 98(10):e14637. PubMed ID: 30855449
[TBL] [Abstract][Full Text] [Related]
51. The Association Between Taste Impairment and Serum Zinc Concentration in Adult Patients With Type 2 Diabetes.
Matsugasumi M; Hashimoto Y; Okada H; Tanaka M; Kimura T; Kitagawa N; Tanaka Y; Fukuda Y; Sakai R; Yamazaki M; Oda Y; Nakamura N; Fukui M
Can J Diabetes; 2018 Oct; 42(5):520-524. PubMed ID: 29551654
[TBL] [Abstract][Full Text] [Related]
52. Utility of polaprezinc in reducing toxicities during radiotherapy: a literature review.
Doi H; Kuribayashi K; Kijima T
Future Oncol; 2018 Aug; 14(19):1977-1988. PubMed ID: 30074413
[TBL] [Abstract][Full Text] [Related]
53. [Taste aversions in lung cancer patients treated with cytostatics].
Olafsdottir M; Steinholtz L; Sjödén PO
Lakartidningen; 1986 Jan; 83(3):124-5, 128-9. PubMed ID: 3003472
[No Abstract] [Full Text] [Related]
54. Applicability of zinc complex of L-carnosine for medical use.
Matsukura T; Tanaka H
Biochemistry (Mosc); 2000 Jul; 65(7):817-23. PubMed ID: 10951100
[TBL] [Abstract][Full Text] [Related]
55. A double-blind study of the therapeutic efficacy of zinc gluconate on taste disorder.
Yoshida S; Endo S; Tomita H
Auris Nasus Larynx; 1991; 18(2):153-61. PubMed ID: 1741708
[TBL] [Abstract][Full Text] [Related]
56. Increase in Carbohydrate Antigen 19-9 Levels without Tumor Progression after Polaprezinc Administration that Induced Deep Vein Thrombosis in a Colon Cancer Patient.
Naito M; Torii R; Hashimoto Y; Kawamoto Y; Hayashi K; Shinoda H; Honjo Y; Hiroyoshi M
Chemotherapy; 2019; 64(3):163-166. PubMed ID: 31655804
[TBL] [Abstract][Full Text] [Related]
57. Preventive effect of zinc compounds, polaprezinc and zinc acetate against the onset of hepatitis in Long-Evans Cinnamon rat.
Sugawara N; Katakura M; Sugawara C
Res Commun Mol Pathol Pharmacol; 1999 Feb; 103(2):167-76. PubMed ID: 10461683
[TBL] [Abstract][Full Text] [Related]
58. [Clinical experiences of the medication to taste disturbance by serum trace deficiency, especially serum iron deficiency].
Negoro A; Umemoto M; Nin T; Fujii M; Sakagami M
Nihon Jibiinkoka Gakkai Kaiho; 2004 Mar; 107(3):188-94. PubMed ID: 15103944
[TBL] [Abstract][Full Text] [Related]
59. A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation.
Ripamonti C; Zecca E; Brunelli C; Fulfaro F; Villa S; Balzarini A; Bombardieri E; De Conno F
Cancer; 1998 May; 82(10):1938-45. PubMed ID: 9587128
[TBL] [Abstract][Full Text] [Related]
60. [Efficacy and safety of polaprezinc as a preventive drug for radiation-induced stomatitis].
Masayuki F; Norihiko K; Keita T; Miwa I; Masayuki I; Toshihiko I; Hiromi F; Chikaaki M; Norio N
Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Mar; 62(4):144-50. PubMed ID: 12043217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
